Metraipolis › archive › dc_4dcd13f8435a

Doxycycline treatment for drug-resistant Mycoplasma pneumoniae pneumonia and evaluation of key predictive factors for refractory disease — Europe PMC PMID:42027822

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42027822
DOI
10.3389/fmed.2026.1714717
License (as archived)
solo-consultazione
Archived
2026-10-17T09:47:01.909Z
SHA-256 of the archived text
a8c71c6a0c0a22555e65c132ab7b7d04c1c70255c9fa154b7545129b77665d9b
Stable URL of this page
https://metraipolis.com/documento/dc_4dcd13f8435a

How to cite

Doxycycline treatment for drug-resistant Mycoplasma pneumoniae pneumonia and evaluation of key predictive factors for refractory disease — Europe PMC PMID:42027822 — Europe PMC (en), https://europepmc.org/article/MED/42027822 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4dcd13f8435a (Metraipolis archive dc_4dcd13f8435a, sha256 a8c71c6a0c0a22555e65c132ab7b7d04c1c70255c9fa154b7545129b77665d9b)
BibTeX
@misc{dc4dcd13f8435a,
  title = {Doxycycline treatment for drug-resistant Mycoplasma pneumoniae pneumonia and evaluation of key predictive factors for refractory disease — Europe PMC PMID:42027822},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42027822},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4dcd13f8435a; sha256 a8c71c6a0c0a22555e65c132ab7b7d04c1c70255c9fa154b7545129b77665d9b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42027822. Agents can read the archived copy with the MCP tool read_document.